- Research article
- Open Access
Homologs of genes expressed in Caenorhabditis elegans GABAergic neurons are also found in the developing mouse forebrain
Neural Development volume 5, Article number: 32 (2010)
In an effort to identify genes that specify the mammalian forebrain, we used a comparative approach to identify mouse homologs of transcription factors expressed in developing Caenorhabditis elegans GABAergic neurons. A cell-specific microarray profiling study revealed a set of transcription factors that are highly expressed in embryonic C. elegans GABAergic neurons.
Bioinformatic analyses identified mouse protein homologs of these selected transcripts and their expression pattern was mapped in the mouse embryonic forebrain by in situ hybridization. A review of human homologs indicates several of these genes are potential candidates in neurodevelopmental disorders.
Our comparative approach has revealed several novel candidates that may serve as future targets for studies of mammalian forebrain development.
Proper forebrain patterning and cell-fate specification lay the foundation for complex behaviors. These neurodevelopmental events in large part depend on a series of gene expression refinements (reviewed in ) that commit cells to express certain phenotypic features that define circuit formation. Relatively subtle disturbances in development may underlie the etiology of neurodevelopmental disorders, especially when alternative cognitive phenotypes do not have an apparent malformation at the gross anatomical level. In the forebrain, cells producing γ-aminobutyric acid (GABAergic interneurons) have been implicated in neurodevelopmental disorders, including autism and schizophrenia [2–4]. These neurons are composed of a diverse class of cells providing a wide range of control of neural activity, and vary in neuroanatomical location, electrophysiological properties, transcriptome/proteome and innervation patterns as either local circuit or long-range projection neurons . As with other cell types, the diversity of GABAergic neurons has its basis in different developmental origins, with timing and location of birth playing key roles in cell fate [1, 6–8].
Despite the phenotypic variety of GABAergic neurons, all use GABA as a neurotransmitter. In mammals, GABA is produced by one of two GABA-synthesizing enzymes, glutamic acid decarboxylase (GAD)65 or GAD67. These closely related enzymes are orthologs of the Caenorhabditis elegans protein UNC-25, which is found only in cells that produce GABA. Because UNC-25/GAD and other components of the GABA synthetic pathway are highly conserved, it is likely that mammalian orthologs of some of the genes that specify GABAergic cell fate in C. elegans embryogenesis may also control GABAergic fate specification during mammalian embryogenesis.
We have explored this hypothesis in an effort to define new candidates for regulating forebrain GABAergic cell fate that may be highly conserved across evolutionarily distant taxa. This discovery-based approach (Figure 1) complements existing analyses of the transcriptomes of subpopulations of mammalian GABAergic cells [9–13]. Thus, by using data from the transcription profiling of GABAergic cells in embryonic C. elegans, in combination with bioinformatics analyses, we report here transcripts with sequence homologs that may also be involved in GABAergic fate specification in mammals. We focused our attention on transcripts with gene regulation ontologies. To probe the potential role of these conserved players in mammalian development, we mapped these gene products in the developing mouse forebrain, with a selective focus on the telencephalon. As a proof of principle, this strategy identified several gene products already known to play a role in the specification of forebrain GABAergic interneurons in mammals. Additionally, our approach identified several previously unexplored gene products that serve as promising candidates for future investigation of forebrain patterning.
Materials and methods
C. elegans transcription profiling
A microarray profiling of C. elegans cells (MAPCeL) strategy was used to obtain a transcriptome profile of C. elegans GABAergic neurons [14, 15]. A complete description of the methods used for this study and the GABAergic neuron expression profile will be reported elsewhere (S Barlow, L Earls, J Watson, C Spencer, K Watkins, D Miller, manuscript in preparation). Briefly, the unc-25::GFP marker was used to label C. elegans GABAergic neurons. unc-25::GFP-expressing embryos were dissociated with chitinase and cultured for 24 hours and viable unc-25::GFP labeled cells were isolated by fluorescence activated cell sorting (FACS). Total RNA was purified from both the sorted unc-25::GFP positive cells and from the reference sample of all embryonic cells. The RNAs were amplified and hybridized to the Affymetrix C. elegans array. Average signal intensities were calculated from three independent isolates of the unc-25::GFP cells and from four replicates of the reference samples. A comparison of the unc-25::GFP and reference data sets identified 673 transcripts showing elevated expression (1.7×) in GABAergic neurons at a false discovery rate (FDR) ≤ 1% ).
Genes in the list of GABAergic enriched transcripts with Gene Ontology (GO) terms related to DNA and transcription regulation were analyzed for potential homology to mouse transcripts. Because functional homology is conserved at the protein level, we generated a list of C. elegans proteins from the list of corresponding transcripts and then used BLASTP  analysis available at WormBase  from June 2005 to November 2008 (wormbase releases WS144 to WS196) to identify the closest matching mouse protein sequence homologs. We then used this list of mouse protein homologs to generate the corresponding catalogue of mouse transcripts for in situ hybridization analysis. We did not distinguish among potential splice variants and/or protein isoforms for a given single gene locus. To further rank potential candidates, we performed BLASTP in the reverse direction; after generating the list of mouse protein sequence homologs, those proteins were used to identify the best sequence homologs in the C. elegans proteome.
Mouse care and use
Timed pregnant C57Bl6j mice were bred in-house from founders originating from Jackson Labs under protocols approved by the Institutional Animal Care and Use Committee of Vanderbilt University. Mice were maintained on a 12:12 light-dark cycle and were permitted food and water ad libitum. Noon on the day following a time-delimited overnight pairing was considered embryonic day 0.5 (E0.5). Pregnant females were readily identifiable at E14.5 and were deeply anesthetized with isofluorane vapors followed by rapid decapitation in order to harvest embryos. Expression patterns of genes at this fetal age were analyzed because it is a mid-point in the age-range for cortical GABAergic neuron production and migration in the mouse forebrain . Thus, we hypothesized that expression patterns related to GABAergic neuron specification and differentiation likely would be apparent at this age.
I.M.A.G.E. clones were obtained from ATCC (Manassas, VA, USA) and Open Biosystems (Huntsville, AL, USA) for the mouse transcripts (Additional file 1). The identity of each I.M.A.G.E. clone was confirmed by sequencing at the Vanderbilt DNA Sequencing Facility. When necessary, due to cDNA size or the plasmid vector, we subcloned the I.M.A.G.E. clone into a separate vector (Additional file 2). These subclones were also sequenced to confirm identity and orientation. Plasmids were linearized and transcribed using T7, Sp6 or T3 polymerase (Promega, Madison, WI, USA) depending on the plasmid vector, by standard methods. Digoxigenin-11-uridine-5'-triphosphate (0.35 mM; Roche, Indianapolis, IN, USA) was included in the transcription reaction to allow for non-radioactive colorimetric detection of transcripts.
In situ hybridization
Fetuses at E14.5 were harvested into cold phosphate-buffered saline and crown-rump length (11 to 12 mm) confirmed. Whole heads or microdissected brains were immersion fixed for 24 hours in 4% formaldehyde in 0.156 M NaH2PO4, 0.107 M NaOH, pH 7.12 with HCl. After fixation, brains were cryoprotected in graded 10, 20 and 30% sucrose in phosphate-buffered saline followed by embedding in TFM Tissue Freezing Medium (Triangle Biomedical Sciences, Inc., Durham, NC, USA) over liquid nitrogen. Brains were stored at -80°C until cryostat sectioning into 6 series at 20 microns each. Slides containing the tissue were stored at -80°C until they were fixed, acetylated and dehydrated, and then returned to -80°C until in situ hybridization was performed. In situ hybridization was performed on a Tecan Evo 150 (Tecan Group Ltd, Männendorf, Switzerland) following the Allen Brain Atlas  and GenePaint  protocols (Additional files 3 and 4). After the machine completed the described protocol, BCIP and NBT (Roche) were applied manually. The time in color development ranged from 30 minutes to 4 hours. After color development, the slides were rinsed four times with double distilled water and then twice with 4% formaldehyde. Slides were removed from the machine, dehydrated through a series of alcohols and coverslipped with VectaMount (Vector Laboratories, Burlingame, CA, USA).
Microscopy was performed using an Axioplan II microscope (Zeiss, Jena, Germany), and micrographs were acquired with a Zeiss AxioCam HRc camera (Zeiss) in Axiovision 4.1 software (Zeiss). Low-magnification images were collected and linearly adjusted for brightness and contrast using Adobe Photoshop (version 7.0, Adobe, San Jose, CA, USA). No other image alterations other than resizing were performed. All figures were prepared digitally in PowerPoint 2007 (Microsoft, Redmond, WA, USA).
Genes expressed in C. elegans GABAergic neurons
C. elegans embryonic GABAergic neurons were profiled by the MAPCeL approach in which unc-25::GFP labeled cells were isolated by FACS for microarray analysis. Comparison to a reference data set obtained from all embryonic cells revealed 673 transcripts with enriched (1.7×) expression in GABAergic neurons. Strong enrichment of established GABAergic neuron markers, such as unc-25 (glutamic acid decarboxylase; 61×), unc-47 (vesicular GABA transporter; 7×) and acr-9 (nicotinic acetylcholine receptor; 25×) [20, 21] indicate that other transcripts in this data set are also likely to be highly expressed in embryonic C. elegans GABAergic neurons in vivo (S Barlow, L Earls, J Watson, C Spencer, K Watkins, D Miller, manuscript in preparation). Seventy five percent of the highly expressed transcripts had defined gene ontologies and of those, 17 transcripts (2.5%) in this list met criteria for DNA regulation-related gene ontologies (Table 1).
Bioinformatics assessment of mouse homologs
The original list of 17 C. elegans candidate transcription factors was used to identify 68 mouse homologs by BLASTP with an expectation cut off of ≤ E-3 (Table 2). The average number of mouse homologs was 3.8 for each C. elegans protein, with a mode of 3, a minimum of 2 and a maximum of 8 sequence homologs. Because of the similarity among certain C. elegans transcripts, three mouse proteins (Hnf4A, Hnf4G and Ezh2) appeared on the list more than once. When considering these duplications, there were 62 unique gene products to pursue for expression analysis. This analytical strategy appears to be suitable for identifying neurodevelopmental candidates, as we found that several mouse orthologs with homology to C. elegans transcripts have a known role in forebrain patterning. In particular, genes with selective roles in determining GABAergic phenotype in mammals were identified, including known players in the forebrain (Nkx2. 1, Arx, Cux2), midbrain (Pitx2) and spinal cord (Cux2).
Performing the reverse BLASTP from mouse proteins to worm proteins informed the strength of the sequence homology for the mouse and worm proteins relative to the other potential homologues in C. elegans. This reverse BLASTP can help rank-order candidates for further functional assessment in the future. If the reverse BLASTP returned the original C. elegans as the hit with the highest E-value, then 'yes' was entered in the R BLASTP column in Table 2. If the reverse BLASTP had a different C. elegans protein as the top hit, then a value of 'no' was entered in Table 2. Of the 68 mouse proteins, 22 had the original worm protein as the top reciprocal hit for sequence homology in the reverse BLASTP.
In situ hybridization mapping of mouse sequence homologs
Our criterion for potential relevance of mouse gene products in the specification of telencephalic interneurons was that transcripts must be present in known GABAergic proliferative zones (such as the medial, lateral and caudal subdivisions of the ganglionic eminence), although they need not be exclusively expressed in those brain areas. Representative expression patterns are depicted in Figure 2 with complete results summarized in Table 3. In addition to the expression data generated here, other sources for assessment and/or confirmation of expression were used, including GenePaint , Brain Gene Expression Map (BGEM)  and the Allen Brain Atlas .
Of the 62 unique transcripts, 57 have sufficient data to ascertain brain expression (Table 3). Of these, 52 (91%) exhibited brain expression. We narrowed our focus to known areas of cortical interneuron generation, migration and maturation, particularly the ganglionic eminences. In particular, we closely examined the proliferative ventricular zone (VZ), subventricular zone (SVZ), mantle of the subpallium and the pallium. A majority (38 of 52, 73%) of transcripts from our list were detected in the VZ, although this expression was not restricted to ventral proliferative zones. Rather, these transcripts were more broadly expressed throughout the dorsal and ventral VZ. Sixty percent (31 of 52) of transcripts were expressed in the cortex, 35% (18 of 52) in the mantle and 33% (17 of 52) in the SVZ. Expression patterns that included multiple embryonic histogenic forebrain areas were evident for the majority of transcripts.
We observed three general patterns of expression (Table 3 and Figure 2): pattern 1, expression throughout the forebrain (for example, Ctnnb1, Tcfap4); pattern 2, expression in post-mitotic cells based on location in the mantle zone and cortical plate (for example, Cux2, Fox1, Myst3); and pattern 3, expression mainly in proliferative zones (for example, Hist1h1a, Ncl, Ezh2, Suv39h1). For patterns 2 and 3, expression was generally mosaic and limited to subsets of cells. Although more rare, we did observe expression of some transcripts in discrete areas, such as the well known pattern of Nkx2.1 in the medial ganglionic eminence (MGE; Figure 2) and Pitx2 (data not shown) in discrete nuclei outside of established forebrain GABAergic proliferative zones.
OMIM and disease linkage meta-analysis
Human orthologs of the mouse genes were identified through NCBI Homologene. Only one mouse gene, Refbp2, does not yet have an identified human ortholog. Manual pBLAST of non-redundant protein entries also revealed no significant human homology to mouse Refbp2. The genes identified in this work are scattered throughout the human genome (Figure 3; Additional file 5). In order to assess any potential bias in the distribution of the homologs, we tallied the genes on each chromosome as a percentage of the genes in this study. We then compared those fractions with the distribution of all the genes in the genome (data were obtained from NCBI Homo Sapiens build 37.1). A difference score of observed-expected was calculated for each chromosome. We then standardized the difference scores and estimated confidence intervals (degrees of freedom 23). In general, the human homologs of transcripts enriched in worm embryonic GABAergic cells were distributed evenly throughout the genome. The only exception was chromosome 14, in which the standardized difference score fell outside of the 98% confidence interval. Chromosome 6 was just inside the 95% confidence interval, although several of the genes (IP6K3, TAF11, TRERF1, RXRB, HIST1H1A) cluster near 6p21, a known site of suppressed recombination . This region is associated with reading disability  and schizophrenia .
To identify known diseases or disorders associated with the identified genes from the C. elegans screen, each human gene was used as a search term in Online Mendelian Inheritance in Man (OMIM). Of the 62 transcripts, 17 had OMIM entries. Of these, only three were relevant to neurocognitive phenotypes (Table 4). Mutations in ARX are causal for X-linked mental retardation , PHOX2B mutations are associated with congenital central hypoventilation syndrome , and mutations in NKX2.1 are associated with congenital chorea .
In addition to OMIM analysis, we surveyed the literature for gene association studies that may implicate any of the genes identified in this study with neurocognitive disruption as evident in autism spectrum disorders (ASDs), mental retardation, schizophrenia, seizure disorders or bipolar disorder. These findings are presented in Table 4. ARX (reviewed in ) is the best-known contributor to phenotypic disturbances among the transcription factors in our list. A2BP1 (human FOX1) appears to have a similar level of pleiotropy. While A2BP1 is relatively understudied, it has been associated with ASD , mental retardation and seizure activity .
Finally, the hypothesis that disturbances in GABAergic interneurons may play a role in ASD, combined with the emerging interest in endophenotype analysis in trait genetics in ASD, prompted a comparison of the 62 genes to chromosomal regions associated with ASD endophenotypes, rather than association with full ASD diagnosis. Specifically, we relied on summarized evidence from the literature of chromosomal association with autism endophenotype data reviewed by Losh et al. . The chromosomal positions of selected genes are presented in Table 4 along with the associated autism endophenotypes for those chromosomal positions. There are several potential candidates for further analysis of autism endophenotypes. In particular, EZH2 stands out, as it is located at 7q35-36, within a replicated linkage peak for ASD genetics, including language, communication and developmental regression endophenotypes [38–40]. Additionally, A2BP1(FOX1) is included in a chromosomal position associated with autism [35, 36].
In this report, we adopted a conservation-based bioinformatic approach to identify potential molecular regulators of GABAergic identity in the mammalian telencephalon. GFP-marked GABAergic neurons from the nematode, C. elegans, were isolated by FACS for microarray profiling. These data revealed enrichment (≥ 1.7×) of 17 transcripts encoding conserved proteins with potential roles in gene regulation in the nematode. BLASTP of these C. elegans proteins identified mouse homologs and 62 independent transcripts corresponding to these mammalian transcription factors were assessed for expression in E14.5 mouse brain. The data generated in our comparative strategy revealed several highly conserved players in GABAergic interneuron differentiation, including Arx, Nkx2.1 and Cux2[22–24]. The positive identification of these transcripts supports the utility of our bioinformatic approach as a productive strategy for identifying conserved determinants of neuronal fate. Of the reciprocal BLASTP top hits, 14 unique transcripts showed relevant in situ hybridization patterns for telencephalic GABAergic neurogenesis, with 3 having known roles (Arx, Cux1, Cux2). Indeed, mutations in ARX have been associated with human brain function and interneuron pathology as identified in OMIM . The 11 remaining top reciprocal hits with relevant expression patterns serve as novel candidate genes (Ip6k1, Ip6k2, Trerf1, C130039O16Rik, Ezh2, Taf11, Med6, Thoc4, Refbp2, Med8, Tcfap4). While not top reciprocal hits, based on striking expression pattern alone, Hist1h1a, Fox1, Myst3 and Suv39h1 warrant further attention. This is especially true as reciprocity is not a perfect predictor of candidacy, as two proteins with known function in GABAergic specification were not top reciprocal hits (NKX2.1 and beta-Catenin).
Mammalian GABAergic cells are generated in the preoptic area and ganglionic eminence of the ventral pallium during embryogenesis [8, 42–44]. The three main subdivisions of the ganglionic eminence-lateral (LGE), medial (MGE) and caudal (CGE)-generate a diverse portfolio of GABAergic cells. The LGE produces GABAergic projection neurons of the striatum and interneurons of the amygdala and the olfactory bulbs whereas the MGE and CGE produce the majority of cortical and striatal interneurons, although each contributes a different repertoire of cell types. Cells from the MGE (for example, Nkx2.1-expressing cells) settle in cortical layers in an inside-out fashion based on cell birth date, whereas the most ventral MGE cells generate neurons of the globus pallidus and striatal cholinergic neurons . In contrast, cells from the CGE tend to migrate to upper layers, independent of birthday, and comprise 15 to 30% of all cortical interneurons . It is curious that of all of the transcription factors that we mapped, Nkx2.1 was the only one that was limited to one of the three progenitor pools.
It is clear that the gene regulatory transcripts identified in our study, with the exception of Nkx2.1, do not delineate these well-known pools of progenitor populations. The absence of tissue specificity could mean that these transcription factors exercise general roles in neuronal differentiation as opposed to functioning as selective determinants of GABAergic fate. However, the broader expression beyond the boundaries of these defined progenitor zones does not preclude a role for the protein products of these transcripts in contributing to the development of a selective neuronal type. For example, these candidates may be permissive for a particular fate or act in combination with other gene products with more limited expression patterns.
The data generated by our comparative approach blend with and add to the existing data on mammalian transcription factors that could play a role in the full development of GABAergic fates. There have been several efforts in mouse embryogenesis to use transcription profiling of microdissected GABAergic proliferative zones or fluorescent sorting of enhanced GFP (EGFP)-positive interneurons in dissected embryonic brain. For example, Batista-Brito et al.  used FACS to isolate embryonic interneurons from presumptive neocortex of E13.5 and E15.5 Dlx5/6Cre-IRIS-EGFP mice. They contrasted the transcriptomes of EGFP-positive (interneurons) and EGFP-negative cells (all other cell types) and identified several enriched transcripts, including Arx and Cux2, as in our study. Because of the region dissected, Nkx2.1 was not enriched, as its expression wanes as interneurons leave the medial ganglionic eminence. They also identified several other candidate transcription factors, including some with association with neurological disorders. Faux et al.  performed a similar experiment contrasting the transcriptomes of interneurons in the cortex versus the ganglionic eminence using GAD67-EGFP FACS isolated cells obtained at E13.5 and E15.5. Among other transcription factors, Faux et al. also show increased expression of Cux2. Cux2 was also identified in a similar study by Marsh et al. . By changing the contrasted pools of mRNA, the Faux et al. study addressed a different question than the Batista-Brito et al. study. The purpose of the Faux et al. study was to enrich for transcripts that may play a role in the migration of interneurons, while the Batista-Brito et al. study addressed the question of what genes are differentially expressed in interneurons versus other cell types in the embryonic cortex. Clearly, the contrasted pool of mRNA makes a difference in what transcripts appear to play a role in aspects of interneuron specification , migration  and maturation . Indeed, contrasting mRNA pools from CGE, LGE and MGE can provide candidates for specifying interneuron subtype .
While the comparative approach used here has identified novel potential candidates in the specification of interneurons, there are limitations. The experimental design would not detect elements of chromatin structure or microRNAs, for example, as mechanisms of transcriptional regulation. Our analysis was limited to transcripts that encode proteins involved in gene regulation; other protein classes (for example, receptor tyrosine kinases, ion channels) could also be involved. Moreover, the results are correlational; the expression patterns of these novel candidates overlap with areas that produce GABAergic cells, but do not show that these transcripts participate in GABA fate. Functional studies will be necessary to determine a role for these potential novel players. Additionally, while the comparative data used in this study are based on protein sequence homologies, the ultimate goal is to identify functional orthologs across species. Because true functional orthology is determined over time with experimental methods outside of the scope of this manuscript, we implore the reader to view these data as a first step on the path to identifying potential functional orthologs in conserved gene regulation networks to specify a GABAergic fate.
While this comparative approach revealed several highly conserved players in GABAergic neurogenesis, including Nkx2.1, Arx and Cux2, we failed to identify some known factors in mammalian forebrain specification, including Olig-2, although we did identify other basic helix-loop-helix (bHLH) transcription factors, such as Tcfap4. Also noticeably absent from the list were Lhx6 (lim-4 in C. elegans), Mash1 and Dlx1/2, all of which have been demonstrated to play a role in GABAergic differentiation in the mammalian forebrain. We note that a related LIM homeodomain protein, LIM-6, is required for differentiation and expression of UNC-25/GAD in a subset of C. elegans GABAergic neurons .
While unc-30 is the top candidate with the highest enrichment in GABAergic cells in the worm data set, none of the mammalian homologs (Pitx1, Pitx2, Pitx3) revealed expression in known GABAergic proliferative zones of the forebrain, even though there was expression in other brain areas at E14.5. Pitx2 is highly expressed in GABA neuron progenitors in diencephalon/mesencephalon , where it is known to drive Gad67 expression . This role is also conserved in the C. elegans homolog, unc-30. In fact, both mammalian Pitx2 and C. elegans unc-30 can both be used to activate Gad67 transcription in vitro and in vivo. While Pitx2 and unc-30 clearly give rise to a GABA phenotype, based on the absence of Pitx2 expression in the forebrain, there are other mechanisms that regulate GABA phenotype in the interneurons of the telencephalon. More than one type of transcription factor or combination of transcription factors likely can drive the GABAergic fate. Indeed, GABAergic fate regulation in the worm offers a striking parallel to the mouse: unc-30 drives GABAergic fate in ventral cord motor neurons but not in GABAergic motor neurons in the head where the LIM homeodomain lim-6 is required; similarly, Pitx2 is highly expressed in diencephalon/mesencephalon GABAergic progenitors and drives Gad67 expression but is not required for differentiation of forebrain GABAergic interneurons that depend on ARX. Additionally, alr-1, the worm homolog of ARX, regulates gene expression in worm GABA motor neurons .
Comparative transcription profiling across diverse taxa is a fruitful approach for generating candidate genes for brain development. Our comparative analysis has pointed to several interesting candidates for the specification of GABAergic cells in the mammalian telencephalon during embryogenesis based on their expression in regions known to produce or contain interneurons. While not exclusively expressed in these regions, Hist1h1a, Ezh2, A2bp1 (Fox1), Suv39h1 and Myst3 are all novel candidates for interneuron development. Furthermore, these candidates represent two relatively understudied classes of gene regulatory proteins in the context of interneuron development, including histone interacting proteins (Hist1h1a, Ezh2, Suv39h1 and Myst3) and RNA regulators (Fox1/A2bp1). As novel candidates for interneuron development, these transcripts may also be candidate genes for, or participate in, pathways giving rise to neurodevelopmental disorders such as autism, mental retardation and schizophrenia. Variation in function of these proteins and their interacting partners might also play a role in brain evolution. These hypotheses remain to be explored.
autism spectrum disorder
caudal ganglionic eminence
enhanced green fluorescent protein
fluorescence activated cell sorting
glutamic acid decarboxylase
green fluorescent protein
lateral ganglionic eminence
medial ganglionic eminence
Online Mendelian Inheritance in Man
Hebert JM, Fishell G: The genetics of early telencephalon patterning: some assembly required. Nat Rev Neurosci. 2008, 9: 678-685. 10.1038/nrn2463.
Levitt P: Disruption of interneuron development. Epilepsia. 2005, 46 (Suppl 7): 22-28. 10.1111/j.1528-1167.2005.00305.x.
Levitt P, Eagleson KL, Powell EM: Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci. 2004, 27: 400-406. 10.1016/j.tins.2004.05.008.
Eagleson KL, Hammock EAD, Levitt P: Interneuron pathophysiologies: paths to neurodevelopmental disorders. Developmental Plasticity of Inhibitory Circuitry. Edited by: Pallas SL. 2010, US: Springer, 167-184. full_text.
Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C: Interneurons of the neocortical inhibitory system. Nat Rev Neurosci. 2004, 5: 793-807. 10.1038/nrn1519.
Butt SJ, Fuccillo M, Nery S, Noctor S, Kriegstein A, Corbin JG, Fishell G: The temporal and spatial origins of cortical interneurons predict their physiological subtype. Neuron. 2005, 48: 591-604. 10.1016/j.neuron.2005.09.034.
Flames N, Marin O: Developmental mechanisms underlying the generation of cortical interneuron diversity. Neuron. 2005, 46: 377-381. 10.1016/j.neuron.2005.04.020.
Wonders CP, Anderson SA: The origin and specification of cortical interneurons. Nat Rev Neurosci. 2006, 7: 687-696. 10.1038/nrn1954.
Batista-Brito R, Machold R, Klein C, Fishell G: Gene expression in cortical interneuron precursors is prescient of their mature function. Cereb Cortex. 2008, 18: 2306-2317. 10.1093/cercor/bhm258.
Faux C, Rakic S, Andrews W, Yanagawa Y, Obata K, Parnavelas JG: Differential gene expression in migrating cortical interneurons during mouse forebrain development. J Comp Neurol. 2010, 518: 1232-1248.
Marsh ED, Minarcik J, Campbell K, Brooks-Kayal AR, Golden JA: FACS-array gene expression analysis during early development of mouse telencephalic interneurons. Dev Neurobiol. 2008, 68: 434-445. 10.1002/dneu.20602.
Okaty BW, Miller MN, Sugino K, Hempel CM, Nelson SB: Transcriptional and electrophysiological maturation of neocortical fast-spiking GABAergic interneurons. J Neurosci. 2009, 29: 7040-7052. 10.1523/JNEUROSCI.0105-09.2009.
Willi-Monnerat S, Migliavacca E, Surdez D, Delorenzi M, Luthi-Carter R, Terskikh AV: Comprehensive spatiotemporal transcriptomic analyses of the ganglionic eminences demonstrate the uniqueness of its caudal subdivision. Mol Cell Neurosci. 2008, 37: 845-856. 10.1016/j.mcn.2008.01.009.
Fox RM, Von Stetina SE, Barlow SJ, Shaffer C, Olszewski KL, Moore JH, Dupuy D, Vidal M, Miller DM: A gene expression fingerprint of C. elegans embryonic motor neurons. BMC Genomics. 2005, 6: 42-10.1186/1471-2164-6-42.
Von Stetina SE, Watson JD, Fox RM, Olszewski KL, Spencer WC, Roy PJ, Miller DM: Cell-specific microarray profiling experiments reveal a comprehensive picture of gene expression in the C. elegans nervous system. Genome Biol. 2007, 8: R135-10.1186/gb-2007-8-7-r135.
Altschul SF, Wootton JC, Gertz EM, Agarwala R, Morgulis A, Schäffer AA, Yu YK: Protein database searches using compositionally adjusted substitution matrices. FEBS J. 2005, 272: 5101-5109. 10.1111/j.1742-4658.2005.04945.x.
Allen Brain Atlas. [http://www.brain-map.org/]
Jin Y, Jorgensen E, Hartwieg E, Horvitz HR: The Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase and is required for synaptic transmission but not synaptic development. J Neurosci. 1999, 19: 539-548.
Cinar H, Keles S, Jin Y: Expression profiling of GABAergic motor neurons in Caenorhabditis elegans. Curr Biol. 2005, 15: 340-346. 10.1016/j.cub.2005.02.025.
Butt SJ, Sousa VH, Fuccillo MV, Hjerling-Leffler J, Miyoshi G, Kimura S, Fishell G: The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes. Neuron. 2008, 59: 722-732. 10.1016/j.neuron.2008.07.031.
Friocourt G, Parnavelas JG: Mutations in ARX result in several defects involving GABAergic neurons. Front Cell Neurosci. 2010, 4: 4
Cubelos B, Sebastián-Serrano A, Kim S, Redondo JM, Walsh C, Nieto M: Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons. Dev Neurobiol. 2008, 68: 917-925. 10.1002/dneu.20626.
Westmoreland JJ, McEwen J, Moore BA, Jin Y, Condie BG: Conserved function of Caenorhabditis elegans UNC-30 and mouse Pitx2 in controlling GABAergic neuron differentiation. J Neurosci. 2001, 21: 6810-6819.
Iulianella A, Sharma M, Vanden Heuvel GB, Trainor PA: Cux2 functions downstream of Notch signaling to regulate dorsal interneuron formation in the spinal cord. Development. 2009, 136: 2329-2334. 10.1242/dev.032128.
Brain Gene Expression Map. [http://www.stjudebgem.org/web/mainPage/mainPage.php]
Malfroy L, Roth MP, Carrington M, Borot N, Volz A, Ziegler A, Coppin H: Heterogeneity in rates of recombination in the 6-Mb region telomeric to the human major histocompatibility complex. Genomics. 1997, 43: 226-231. 10.1006/geno.1997.4800.
Ahn J, Won TW, Kaplan DE, Londin ER, Kuzmic P, Gelernter J, Gruen JR: A detailed physical map of the 6p reading disability locus, including new markers and confirmation of recombination suppression. Hum Genet. 2002, 111: 339-349. 10.1007/s00439-002-0771-x.
Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Børglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Böttcher Y, Olesen J, Breuer R, Möller HJ, Giegling I: Common variants conferring risk of schizophrenia. Nature. 2009, 460: 744-747.
Kato M, Das S, Petras K, Kitamura K, Morohashi K, Abuelo DN, Barr M, Bonneau D, Brady AF, Carpenter NJ, Cipero KL, Frisone F, Fukuda T, Guerrini R, Iida E, Itoh M, Lewanda AF, Nanba Y, Oka A, Proud VK, Saugier-Veber P, Schelley SL, Selicorni A, Shaner R, Silengo M, Stewart F, Sugiyama N, Toyama J, Toutain A, Vargas AL: Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum Mutat. 2004, 23: 147-159. 10.1002/humu.10310.
Amiel J, Laudier B, Attié-Bitach T, Trang H, de Pontual L, Gener B, Trochet D, Etchevers H, Ray P, Simonneau M, Vekemans M, Munnich A, Gaultier C, Lyonnet S: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet. 2003, 33: 459-461. 10.1038/ng1130.
Pohlenz J, Dumitrescu A, Zundel D, Martiné U, Schönberger W, Koo E, Weiss RE, Cohen RN, Kimura S, Refetoff S: Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest. 2002, 109: 469-473.
Sherr EH: The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes. Curr Opin Pediatr. 2003, 15: 567-571. 10.1097/00008480-200312000-00004.
Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, Cook E, Geschwind DH: Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet. 2007, 144B: 869-876. 10.1002/ajmg.b.30530.
Bhalla K, Phillips HA, Crawford J, McKenzie OL, Mulley JC, Eyre H, Gardner AE, Kremmidiotis G, Callen DF: The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene. J Hum Genet. 2004, 49: 308-311. 10.1007/s10038-004-0145-4.
Losh M, Sullivan PF, Trembath D, Piven J: Current developments in the genetics of autism: from phenome to genome. J Neuropathol Exp Neurol. 2008, 67: 829-837. 10.1097/NEN.0b013e318184482d.
Alarcon M, Cantor RM, Liu J, Gilliam TC, Geschwind DH: Autism Genetic Research Exchange Consortium. Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet. 2002, 70: 60-71. 10.1086/338241.
Alarcon M, Yonan AL, Gilliam TC, Cantor RM, Geschwind DH: Quantitative genome scan and ordered-subsets analysis of autism endophenotypes support language QTLs. Mol Psychiatry. 2005, 10: 747-757. 10.1038/sj.mp.4001666.
Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D, Lord C, Iversen P, Hoh J, Ott J, Gilliam TC: A genomewide screen for autism susceptibility loci. Am J Hum Genet. 2001, 69: 327-40. 10.1086/321980.
Okazaki S, Ohsawa M, Kuki I, Kawawaki H, Koriyama T, Ri S, Ichiba H, Hai E, Inoue T, Nakamura H, Goto Y, Tomiwa K, Yamano T, Kitamura K, Itoh M: Aristaless-related homeobox gene disruption leads to abnormal distribution of GABAergic interneurons in human neocortex: evidence based on a case of X-linked lissencephaly with abnormal genitalia (XLAG). Acta Neuropathol. 2008, 116: 453-462. 10.1007/s00401-008-0382-2.
Gelman DM, Martini FJ, Nóbrega-Pereira S, Pierani A, Kessaris N, Marín O: The embryonic preoptic area is a novel source of cortical GABAergic interneurons. J Neurosci. 2009, 29: 9380-9389. 10.1523/JNEUROSCI.0604-09.2009.
Wonders C, Anderson SA: Cortical interneurons and their origins. Neuroscientist. 2005, 11: 199-205. 10.1177/1073858404270968.
Xu Q, Cobos I, De La Cruz E, Rubenstein JL, Anderson SA: Origins of cortical interneuron subtypes. J Neurosci. 2004, 24: 2612-2622. 10.1523/JNEUROSCI.5667-03.2004.
Flandin P, Kimura S, Rubenstein JL: The progenitor zone of the ventral medial ganglionic eminence requires Nkx2-1 to generate most of the globus pallidus but few neocortical interneurons. J Neurosci. 2010, 30: 2812-2823. 10.1523/JNEUROSCI.4228-09.2010.
Miyoshi G, Hjerling-Leffler J, Karayannis T, Sousa VH, Butt SJ, Battiste J, Johnson JE, Machold RP, Fishell G: Genetic fate mapping reveals that the caudal ganglionic eminence produces a large and diverse population of superficial cortical interneurons. J Neurosci. 2010, 30: 1582-1594. 10.1523/JNEUROSCI.4515-09.2010.
Hobert O, Tessmar K, Ruvkun G: The Caenorhabditis elegans lim-6 LIM homeobox gene regulates neurite outgrowth and function of particular GABAergic neurons. Development. 1999, 126: 1547-1562.
Martin DM, Skidmore JM, Fox SE, Gage PJ, Camper SA: Pitx2 distinguishes subtypes of terminally differentiated neurons in the developing mouse neuroepithelium. Dev Biol. 2002, 252: 84-99. 10.1006/dbio.2002.0835.
Jin Y, Hoskins R, Horvitz HR: Control of type-D GABAergic neuron differentiation by C. elegans UNC-30 homeodomain protein. Nature. 1994, 372: 780-783. 10.1038/372780a0.
Melkman T, Sengupta P: Regulation of chemosensory and GABAergic motor neuron development by the C. elegans Aristaless/Arx homolog alr-1. Development. 2005, 132: 1935-1949. 10.1242/dev.01788.
Cotter D, Kerwin R, al-Sarraji S, Brion JP, Chadwich A, Lovestone S, Anderton B, Everall I: Abnormalities of Wnt signalling in schizophrenia-evidence for neurodevelopmental abnormality. Neuroreport. 1998, 9: 1379-1383. 10.1097/00001756-199805110-00024.
Toyota T, Yoshitsugu K, Ebihara M, Yamada K, Ohba H, Fukasawa M, Minabe Y, Nakamura K, Sekine Y, Takei N, Suzuki K, Itokawa M, Meerabux JM, Iwayama-Shigeno Y, Tomaru Y, Shimizu H, Hattori E, Mori N, Yoshikawa T: Association between schizophrenia with ocular misalignment and polyalanine length variation in PMX2B. Hum Mol Genet. 2004, 13: 551-561. 10.1093/hmg/ddh047.
Philippi A, Tores F, Carayol J, Rousseau F, Letexier M, Roschmann E, Lindenbaum P, Benajjou A, Fontaine K, Vazart C, Gesnouin P, Brooks P, Hager J: Association of autism with polymorphisms in the paired-like homeodomain transcription factor 1 (PITX1) on chromosome 5q31: a candidate gene analysis. BMC Med Genet. 2007, 8: 74-10.1186/1471-2350-8-74.
Kato T: Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci. 2007, 61: 3-19. 10.1111/j.1440-1819.2007.01604.x.
Gruters A, Biebermann H, Krude H: Neonatal thyroid disorders. Horm Res. 2003, 59 (Suppl 1): 24-29.
We thank Eric Yetter, Christine Svitek, Frank Liu and Deborah Gregory for technical support and Phil Ebert, PhD for facilitating the implementation of the high throughput in situ hybridization protocols. Funding was provided by NIH T32 MH065215 (EADH), a Vanderbilt Kennedy Center Hobbs grant (DMM, LE, PL), NIH R21MH077302 (DMM) and by the Vanderbilt Kennedy Center P30 grant NIH HD015052.
The authors declare that they have no competing interests.
EADH completed the mouse and human informatics, mapped the expression of the mouse transcripts and co-wrote the manuscript. KLE, LE and SB participated in experimental design and edited the manuscript. DM and PL participated in experimental design and writing the manuscript.
Electronic supplementary material
Additional file 2: Table S2. Primers used for the generation of subclones from IMAGE clones used to generate in situ hybridization probes in this study. (DOCX 18 KB)
Additional file 3: Table S3. Modified Allen Brain Atlas in situ hybridization protocol and Eurexpress II SOP on Tecan Evo GenePaint System. (DOCX 17 KB)
About this article
Cite this article
Hammock, E.A., Eagleson, K.L., Barlow, S. et al. Homologs of genes expressed in Caenorhabditis elegans GABAergic neurons are also found in the developing mouse forebrain. Neural Dev 5, 32 (2010). https://doi.org/10.1186/1749-8104-5-32
- GABAergic Neuron
- Ganglionic Eminence
- GABAergic Cell
- Medial Ganglionic Eminence
- Mammalian Forebrain